Department of Surgery »  Faculty »  General Surgery »  Carlos U. Corvera, M.D.
 
Related Websites
Dept. of Surgery Websites

Make a Gift

A gift to the Department of Surgery helps our physicians and scientists find new treatments and cures for serious diseases.

How you can help »

Legendary Surgeon Maurice Galante Dies

Maurice Galante, M.D., a legendary master surgeon at UCSF and renaissance man, died on February 5, 2013. His career is memorialized by the Maurice Galante Lecture Program and Maurice Galante Distinguished Professorship.

Read more >
Department of Surgery »  Faculty »  General Surgery »  Carlos U. Corvera, M.D.

Carlos U. Corvera, M.D.

Associate Professor of Surgery
Chief, Hepatobiliary and Pancreas Surgery
Division of General Surgery

Contact Information

Univeristy of California, San Francisco
Helen Diller Family Comprehensive Cancer Center
1600 Divisadero Street, 4th Floor
San Francisco, CA 94115
tel: 415/353-9888
fax: 415/353-9931
carlos.corvera@ucsfmedctr.org

Education

  • 1983-86 University of California, Davis, CA B.S. Biochemistry College of Agricultural and Environmental Science
  • 1989-93 University of California, San Diego Medical School. M.D. La Jolla, CA

Residencies

  • 1993-1995,University of California, San Francisco, Intern and Resident,Surgery
  • 1995-1998 University of California, San Francisco, Research Fellow Surgery, Division of Gastrointestinal Surgery
  • 998-2000,University of California, San Francisco, Senior Resident Surgery
  • 2000-2001,University of California, San Francisco, Chief Resident Surgery

Fellowships

  • 2001-2002, Memorial Sloan-Kettering Cancer Center, Fellow ,Surgical Oncology, New York, New York
  • 2002-2003, Memorial Sloan-Kettering Cancer Center, Fellow, Hepatobiliary Surgery, New York, New York

Postdoctoral Training

Board Certification

  • American Board of Surgery

Program Affiliations

  • Hepatobiliary and Pancreas Surgery Program
  • UCSF Department of Surgery at the San Francisco VA
  • UCSF Helen Diller Family Comprehensive Cancer Center

Clinical Expertise

Research Interests

  • Proteases and Proteinase Activated Receptors in the Biliary Tract

Biography

Carlos Corvera, M.D. is Associate Professor of Surgery and Chief of Hepatobiliary and Pancreas Surgery at UCSF. A trained surgical oncologist, Dr. Corvera has extensive experience in the treatment of benign and malignant hepatobiliary disease including hepatocellular carcinoma (primary liver cancer), liver metastases, and cancers of the stomach, gall bladder, bile ducts, and pancreas. Additionally, Dr. Corvera performs surgery for melanoma and soft tissue sarcomas. Dr. Corvera specializes in complex and intricate cancer surgeries, including minimally invasive liver resections that greatly minimize post-operative pain and speed recovery. Dr. Corvera, who performs a high volume of such procedures, is also a pioneer and innovator of surgical techniques in the field.

Dr. Corvera graduated from the University of California San Diego School of Medicine. He completed his general surgery residency at UCSF, and prestigious fellowships in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center.

Research Summary

Dr. Covera's scientific research interest is focused on understanding the mechanisms of biliary tract fibrosis and inflammation. More specifically, he is interested in studying the clinical consequences of biliary fibrosis-- mainly cholestatisis. Cholestasis is characterized by impaired bile flow causing a high concentration of bile acids in the liver and the circulation. Prolonged exposure to bile acids in the liver can progress to end-stage liver disease and cirrhosis. In the gastrointestinal tract, the absence of bile flow causes profound local and systemic metabolic disturbances. Dr. Covera is actively investigating the role of a novel cell surface receptor specific for bile acids that may play a critical role in normal and disease states.

Selected Publications

  1. Corvera, C.U., Déry, O., McConalogue, K.M., Böhm, S.K., Khitin, L.M., Kong, W., Caughey, G.H., Payan, D.G., Bunnett, N.W. Mast cell tryptase regulates colonic myocytes through proteinase-activated receptor-2. Journal of Clinical Investigation 100: 1997, pp.1383-1393. Role: Study conception and design, conducted experiments, data analysis and manuscript preparation.
  2. Corvera, C.U., Déry, O, McConalogue K., Gamp, P., Thoma, M. Bahjat A. Caughey G.H., Hollenberg, M.D., Bunnett, N.W. Thrombin and mast cell tryptase regulate guinea pig myenteric neurons through proteinase-activated receptors-1 and -2. Journal of Physiology 517.3 :1999, pp.741-756. Role: Study conception and design, conducted experiments, data analysis and manuscript preparation.
  3. Chang TT, Sawhney R, Monto A, Davoren BJ, Kirkland JG., Stewart L, and Corvera C.U. A Multidisciplinary Treatment Team for Patients with Hepatocellular Cancer at a Veterans Affairs Medical Center Improves Survival. Hepato Pancreato Biliary International Association (HPB), 2008;10(6), pp. 405-411. Role: Study conception and manuscript preparation.
  4. Chang, T.T, and Corvera, C.U. The "Caudate Split" Maneuver for Laparoscopic and Open Liver Resections. Am Coll Surg. 2008 Dec; 207(6) pp. e7 e-9. Role: Study conception and manuscript preparation.
  5. Kirkland, J.G., Cottrell, G.S. Bunnett, N.W. and Corvera,C.U. Agonist of PAR1 and PAR2 stimulate electrogenic secretion in Mouse gallbladder. Am J Physiol Gastrointest Liver Physiol. 293(1): 2007. pp. G335-46, 2007. Role: Study conception and design, conducted experiments, data analysis and manuscript preparation.
View All Publications at UCSF Profiles (Powered by CTSI)

In the News

  • Hepatobiliary & Pancreas Service at UCSF

    UCSF Department of Surgery - Jun 01, 2012

    In July 2011, the Department of Surgery created a new Hepatobiliary and Pancreas Service naming Carlos Corvera M.D., a hepatobiliary surgical oncologist, as its Chief. The multidisciplinary program brings together faculty members from surgery, hepatology, medical oncology, anesthesia, radiology and pathology to care for patients with benign and malignant conditions of the liver, gallbladder, biliary tract and pancreas. The service holds clinics and weekly tumor boards at the Mt. Zion and Parnassus campuses of UCSF. "Rather than isolated silos of care, we have a team approach, which makes a big difference for the overall care of the patients," said Dr. Corvera. "When you are looking at a broad spectrum of disease, there are often competing therapies for which a patient might be a good candidate," said John Roberts, MD, FACS, chief of the UCSF Transplant Service."

    Hepatobiliary & Pancreas Surgery Website
X